Pancreatic Pathology Practice Questions

Q: A 42-year-old female was diagnosed with a cystic neoplasm of the pancreas containing ovarian-type stroma. What is the most likely diagnosis?

Mucinous cystadenoma. The presence of **ovarian-type stroma** is the pathognomonic histological hallmark of **Mucinous Cystic Neoplasms (MCNs)** of the pancreas [1]. These tumors occur almost exclusively in females (95%), typically in the body or tail of the pancreas. The stroma consists of spindle cells that express estrogen and progesterone receptors, mimicking the appearance of the ovarian cortex. **Analysis of Options:** * **A. Mucinous Cystadenoma (Correct):** These are large, multiloculated cysts lined by columnar, mucin-secreting epithelium. The defining feature required for diagnosis is the underlying dense, "ovarian-like" mesenchymal stroma [1]. * **B. Serous Cystadenoma:** These are benign tumors characterized by a "honeycomb" appearance on imaging and a central stellate scar. Histologically, they are lined by cuboidal, glycogen-rich cells and lack ovarian stroma [1]. * **C. Solid Pseudopapillary Neoplasm (SPN):** While also common in young females, SPNs are characterized by discohesive cells forming pseudopapillae and are associated with beta-catenin mutations. They do not contain mucin or ovarian stroma. * **D. Intraductal Papillary Mucinous Neoplasm (IPMN):** These arise within the pancreatic ducts (usually the head). While they produce mucin, they lack the characteristic ovarian-type stroma and occur equally in men and women. **High-Yield Pearls for NEET-PG:** * **MCN Rule of "S":** **S**ex (Females), **S**ite (Tail/Body), **S**troma (Ovarian-type). * **Mnemonic:** "Mucinous is for Mothers" (Females, ovarian stroma). * **Malignant Potential:** Unlike serous cystadenomas, mucinous cystadenomas are considered premalignant and usually require surgical resection. * **Tumor Marker:** High CEA levels in the cyst fluid are suggestive of a mucinous etiology (MCN or IPMN). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 895-897.

Q: The term "pseudo" used in "pseudocyst" is due to its:

Lining. ### Explanation The term **"pseudocyst"** is used to distinguish this collection from a "true cyst" based on its histological structure [1]. **1. Why "Lining" is the correct answer:** In pathology, a **true cyst** is defined as an abnormal sac-like structure lined by **epithelium** (e.g., congenital cysts or serous cystadenomas). A **pancreatic pseudocyst**, which typically develops as a complication of acute or chronic pancreatitis, lacks an epithelial lining [1]. Instead, its wall is composed of **granulation tissue and fibrous tissue** [1]. Because it lacks the defining histological feature of a cyst (the epithelium), it is termed "pseudo" (false). **2. Why other options are incorrect:** * **Contents:** While pseudocysts contain pancreatic enzymes (amylase, lipase), inflammatory exudate, and necrotic debris, the nomenclature is based on the wall structure, not the fluid inside. * **Site:** Pseudocysts are commonly found in the lesser sac, but their location does not determine the "pseudo" prefix [1]. * **Course:** The clinical course (resolution vs. complication) is a result of the pathology, not the reason for its name. ### High-Yield Clinical Pearls for NEET-PG: * **Timing:** Pseudocysts typically form **4–6 weeks** after an episode of acute pancreatitis. * **Location:** Most common site is the **lesser sac**, posterior to the stomach [1]. * **Biochemical Marker:** Fluid analysis shows **high amylase levels** and low CEA (distinguishing it from mucinous cystic neoplasms). * **Management:** Most resolve spontaneously; intervention (e.g., cystogastrostomy) is indicated only if they become symptomatic, infected, or exceed 6 cm and persist beyond 6 weeks [1]. * **Most Common Cause:** Chronic alcoholic pancreatitis in adults; trauma in children. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, p. 895.

Q: What is the most common variety of pancreatic carcinoma?

Adenocarcinoma. **Explanation:** **Adenocarcinoma** (specifically ductal adenocarcinoma) is the most common variety of pancreatic carcinoma, accounting for approximately **85–90%** of all pancreatic malignancies. It originates from the epithelial cells lining the pancreatic ducts. The most frequent location is the **head of the pancreas (60–70%)**, often presenting with the classic triad of painless progressive jaundice, weight loss, and a palpable gallbladder (Courvoisier’s Law). **Analysis of Incorrect Options:** * **Neuroendocrine Tumors (NETs):** These arise from the islet cells (e.g., Insulinoma, Gastrinoma). While they are the second most common group, they represent only about 1–5% of pancreatic tumors. * **Mucous Secreting Tumors:** These include Intraductal Papillary Mucinous Neoplasms (IPMN) and Mucinous Cystadenocarcinomas. While important precursors or variants, they are significantly less common than ductal adenocarcinoma. * **Acinar Cell Cystadenocarcinoma:** This is a very rare subtype (approx. 1%) arising from the exocrine acinar cells rather than the ductal epithelium. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Smoking (strongest environmental factor), chronic pancreatitis, obesity, and DM. * **Tumor Marker:** **CA 19-9** is the most specific marker (used for monitoring, not screening). * **Genetic Mutations:** **K-ras** (most common, >90%), CDKN2A (p16), TP53, and SMAD4. * **Surgery:** **Whipple’s Procedure** (Pancreaticoduodenectomy) is the treatment of choice for resectable tumors of the head. * **Double Duct Sign:** On imaging (ERCP/MRCP), simultaneous dilatation of the common bile duct and the pancreatic duct is highly suggestive of a head of pancreas malignancy.

Q: Which of the following statements regarding genetic mutations associated with pancreatitis is true?

All of the above.. This question tests your knowledge of the genetic basis of chronic pancreatitis, a high-yield topic for NEET-PG. The correct answer is **D (All of the above)** because each option accurately links a specific genetic mutation to its clinical manifestation. ### **Detailed Breakdown:** * **PRSS1 (Cationic Trypsinogen Gene):** Mutations in this gene (most commonly R122H) lead to **Hereditary Pancreatitis**. The mutation prevents the deactivation of trypsin within the pancreas, leading to premature enzyme activation and autodigestion. It follows an autosomal dominant inheritance pattern with high penetrance. * **CFTR (Cystic Fibrosis Transmembrane Conductance Regulator):** While severe mutations cause Cystic Fibrosis, milder "non-classic" mutations are strongly associated with **Idiopathic Chronic Pancreatitis**. These mutations lead to viscous pancreatic secretions and impaired bicarbonate transport, causing ductal obstruction. * **SPINK1 (Serine Protease Inhibitor Kazal-type 1):** This gene normally produces a "safety valve" protein that inhibits small amounts of prematurely activated trypsin. Mutations (commonly N34S) reduce this protective capacity. It is significantly associated with **Tropical Calcific Pancreatitis**, a form of chronic pancreatitis prevalent in southern India. ### **Clinical Pearls for NEET-PG:** * **PRSS1:** Associated with a significantly increased lifetime risk of **Pancreatic Adenocarcinoma** (up to 40-50%). * **SPINK1:** Often referred to as a "disease modifier" rather than a direct cause; it lowers the threshold for pancreatitis triggered by other factors. * **CASR (Calcium-Sensing Receptor):** Another mutation to remember, which predisposes individuals to pancreatitis by affecting calcium homeostasis in the pancreatic acinar cells. * **Triad of Chronic Pancreatitis:** Steatorrhea, Diabetes Mellitus, and Pancreatic Calcification.

Q: A 55-year-old man presents with jaundice. Ultrasonography reveals a 5 cm mass in the head of the pancreas. Endoscopic retrograde cholangiopancreatography with cytologic sampling shows cells with large hyperchromatic nuclei and a high nuclear/cytoplasmic ratio. Small glands composed of these cells are also present in the cytologic preparation. The overall prognosis for this patient is most similar to that of a patient with which of the following malignancies?

Adenocarcinoma of the oesophagus. ***Adenocarcinoma of the oesophagus*** - The patient has **pancreatic head adenocarcinoma**, which is notorious for a very poor prognosis and a **5-year survival rate** of less than 10%. - **Adenocarcinoma of the oesophagus** shares a similarly dismal prognosis due to aggressive local invasion and early lymphatic spread. *Adenocarcinoma of the breast* - This malignancy typically has a much higher **5-year survival rate** (often >90%) due to effective screening programs like **mammography**. - Advanced targeted treatments and hormone therapies significantly improve outcomes compared to pancreatic cancer. *Adenocarcinoma of the colon* - While serious, colonic adenocarcinoma has a significantly better prognosis than pancreatic cancer, especially when detected early via **colonoscopy**. - Modern surgical techniques and adjuvant chemotherapy have improved survival rates for most stages of **colorectal cancer**. *Adenocarcinoma of the prostate* - This is often an **indolent tumor** with a 5-year survival rate approaching 100% for localized or regional disease. - Many patients are managed with **active surveillance** because the disease often progresses much more slowly than highly aggressive visceral cancers.

Q: What is the most common gene associated with pancreatic cancer?

KRAS. **Explanation:** Pancreatic ductal adenocarcinoma (PDAC) follows a well-defined genetic progression model involving the activation of oncogenes and the inactivation of tumor suppressor genes [1]. **Why KRAS is correct:** The **KRAS** gene (located on chromosome 12p) is the most frequently mutated gene in pancreatic cancer, found in **>90-95% of cases**. It is an oncogene that encodes a GTP-binding protein involved in cell signaling. KRAS mutations occur very early in the neoplastic progression (seen even in low-grade PanIN-1 lesions), making it the "initiating" genetic event in the majority of pancreatic malignancies [1]. **Analysis of Incorrect Options:** * **P53 (TP53):** This is the most common tumor suppressor gene mutated in pancreatic cancer (found in ~75% of cases), but it occurs later in the progression (PanIN-3) compared to KRAS [1]. * **SMAD4 (DPC4):** Mutated/deleted in about 55% of cases [1]. It is relatively specific to pancreatic cancer (DPC stands for "Deleted in Pancreatic Carcinoma"), but it is less common than KRAS. * **Rb:** While the p16/CDKN2A pathway (which regulates the Rb checkpoint) is inactivated in 95% of cases, direct mutations of the **Rb gene** itself are not the primary driver in pancreatic cancer compared to its role in retinoblastoma or osteosarcoma [1]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Sequence of Mutations:** KRAS (Early) → CDKN2A/p16 (Intermediate) → TP53 & SMAD4 (Late) [1]. 2. **Tumor Marker:** **CA 19-9** is used for monitoring response to treatment, not for primary screening. 3. **Risk Factors:** Smoking (strongest environmental factor), chronic pancreatitis, and diabetes mellitus. 4. **Location:** 60% occur in the **head of the pancreas**, often presenting with painless obstructive jaundice (Courvoisier’s Law) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 897-900.

Question 1

Which cystic neoplasm of the pancreas has a dismal prognosis?

Accepted Answer

Ductal adenocarcinoma with cystic degeneration

Answer

Serous cystadenoma

Answer

Mucinous cystic neoplasm

Answer

Solid pseudopapillary neoplasm

Question 2

A 42-year-old female was diagnosed with a cystic neoplasm of the pancreas containing ovarian-type stroma. What is the most likely diagnosis?

Accepted Answer

Mucinous cystadenoma

Answer

Serous cystadenoma

Answer

Solid pseudopapillary neoplasm

Answer

Intraductal papillary mucinous neoplasm

Question 3

All of the following are examples of familial multiorgan cancer syndromes associated with pancreatic cancer, EXCEPT:

Accepted Answer

Familial multiple pancreatic adenoma syndrome otherwise specified

Answer

Peutz-Jeghers syndrome

Answer

Hereditary nonpolyposis colorectal cancer

Answer

Li-Fraumeni syndrome

Question 4

The term "pseudo" used in "pseudocyst" is due to its:

Accepted Answer

Lining

Answer

Contents

Answer

Site

Answer

Course

Question 5

What is the most common variety of pancreatic carcinoma?

Accepted Answer

Adenocarcinoma

Answer

Neuroendocrine tumour

Answer

Mucous secreting tumour

Answer

Acinar cell cystadenocarcinoma

Question 6

Which of the following statements regarding genetic mutations associated with pancreatitis is true?

Accepted Answer

All of the above.

Answer

Hereditary pancreatitis is associated with the PRSS1 gene mutation.

Answer

Idiopathic chronic pancreatitis is associated with the CFTR gene mutation.

Answer

Tropical calcific pancreatitis is associated with the SPINK1 gene mutation.

Question 7

A 55-year-old man presents with jaundice. Ultrasonography reveals a 5 cm mass in the head of the pancreas. Endoscopic retrograde cholangiopancreatography with cytologic sampling shows cells with large hyperchromatic nuclei and a high nuclear/cytoplasmic ratio. Small glands composed of these cells are also present in the cytologic preparation. The overall prognosis for this patient is most similar to that of a patient with which of the following malignancies?

Accepted Answer

Adenocarcinoma of the oesophagus

Answer

Adenocarcinoma of the breast

Answer

Adenocarcinoma of the colon

Answer

Adenocarcinoma of the prostate

Question 8

What is the most common gene associated with pancreatic cancer?

Accepted Answer

KRAS

Answer

SMAD

Answer

P53

Answer

Rb

Question 9

A 45-year-old male presents with weight loss, steatorrhea, and malabsorption. A CT scan of the abdomen reveals a questionable mass in the head of the pancreas. A biopsy specimen microscopically reveals chronic inflammation and atrophy of the pancreatic acini with marked fibrosis. No malignancy is identified. What is the most common cause of this patient's condition in adults?

Accepted Answer

Chronic alcoholism

Answer

Abdominal trauma

Answer

Gallstones

Answer

Hyperlipidemia

Question 10

Migratory thrombophlebitis is a classic paraneoplastic syndrome associated with which type of malignancy?

Accepted Answer

Pancreatic cancer

Answer

Bladder cancer

Answer

Breast cancer

Answer

Liver cancer

Pancreatic Pathology — MCQs

Pancreatic Pathology — MCQs

On this page

Practice by Chapter

Want unlimited practice?